A detailed history of Virtu Financial LLC transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 62,027 shares of TPST stock, worth $57,064. This represents 0.01% of its overall portfolio holdings.

Number of Shares
62,027
Previous 28,574 117.07%
Holding current value
$57,064
Previous $112,000 21.43%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$2.01 - $5.44 $67,240 - $181,984
33,453 Added 117.07%
62,027 $136,000
Q1 2024

May 20, 2024

BUY
$3.16 - $4.66 $36,937 - $54,470
11,689 Added 69.23%
28,574 $112,000
Q4 2023

Feb 26, 2024

SELL
$0.23 - $9.77 $1,943 - $82,576
-8,452 Reduced 33.36%
16,885 $74,000
Q3 2023

Nov 14, 2023

BUY
$0.3 - $1.39 $7,601 - $35,218
25,337 New
25,337 $8,000

Others Institutions Holding TPST

About Tempest Therapeutics, Inc.


  • Ticker TPST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,418,900
  • Market Cap $9.59M
  • Description
  • Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...
More about TPST
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.